We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+17.13%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$31.9B
AUM Growth
+$4.19B
Cap. Flow
+$23.1M
Cap. Flow %
0.07%
Top 10 Hldgs %
18.87%
Holding
1,397
New
111
Increased
494
Reduced
445
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$83.9M
2
QDEL icon
QuidelOrtho
QDEL
+$75.7M
3
GXC icon
State Street SPDR S&P China ETF
GXC
+$73.7M
4
TSLA icon
Tesla
TSLA
+$58.1M
5
MSFT icon
Microsoft
MSFT
+$48.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$149M
2
HON icon
Honeywell
HON
+$72.2M
3
IBM icon
IBM
IBM
+$66M
4
INTC icon
Intel
INTC
+$63.3M
5
LMND icon
Lemonade
LMND
+$56M

Sector Composition

Rank Sector Weight
1 Technology 30.89%
2 Healthcare 17.61%
3 Consumer Discretionary 11.58%
4 Financials 10.48%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNA icon
251
Snap-on
SNA
$21.5B
$27.8M 0.09%
162,681
-61,934
-28% -$10.4M
COLD icon
252
Americold
COLD
$4.21B
$27.8M 0.09%
743,538
+40,560
+6% +$1.46M
DGX icon
253
Quest Diagnostics
DGX
$26B
$27.6M 0.09%
231,987
+156,812
+209% +$19.1M
STNE icon
254
StoneCo
STNE
$2.67B
$27.5M 0.09%
327,497
-191,487
-37% -$12.8M
SGEN
255
DELISTED
Seagen Inc. Common Stock
SGEN
$27.5M 0.09%
156,912
+6,506
+4% +$1.21M
ZM icon
256
Zoom
ZM
$27.1B
$27.3M 0.09%
80,906
-38,770
-32% -$17.3M
LRCX icon
257
Lam Research
LRCX
$316B
$27.2M 0.09%
576,920
+438,010
+315% +$18.4M
STLA icon
258
Stellantis
STLA
$17.4B
$27.1M 0.08%
1,495,782
+73,657
+5% +$1.09M
JAZZ icon
259
Jazz Pharmaceuticals
JAZZ
$16.1B
$27M 0.08%
163,886
-1,968
-1% -$293K
EXR icon
260
Extra Space Storage
EXR
$32.3B
$26.8M 0.08%
230,992
-99,308
-30% -$11.3M
A icon
261
Agilent Technologies
A
$39.6B
$26.5M 0.08%
224,000
-85,105
-28% -$9.42M
HUM icon
262
Humana
HUM
$43.9B
$26.5M 0.08%
64,684
+6,333
+11% +$2.63M
KEY icon
263
KeyCorp
KEY
$23.8B
$26.5M 0.08%
1,617,091
+109,743
+7% +$1.6M
CAH icon
264
Cardinal Health
CAH
$53.7B
$26.5M 0.08%
494,595
+36,333
+8% +$1.89M
CTLT
265
DELISTED
CATALENT, INC.
CTLT
$26.5M 0.08%
254,309
+10,739
+4% +$1.04M
FSLR icon
266
First Solar
FSLR
$21.4B
$26.4M 0.08%
266,953
+28,540
+12% +$2.47M
YUMC icon
267
Yum China
YUMC
$15.7B
$26.4M 0.08%
461,977
+165,455
+56% +$9.29M
BR icon
268
Broadridge
BR
$18.4B
$26.3M 0.08%
171,992
+88,524
+106% +$12.8M
NIO icon
269
NIO
NIO
$11.9B
$26.3M 0.08%
538,751
+505,051
+1,499% +$19.5M
XPO icon
270
XPO
XPO
$23.4B
$26.3M 0.08%
636,853
-2,180
-0.3% -$79K
MFC icon
271
Manulife Financial
MFC
$73B
$26.2M 0.08%
1,470,875
-313,486
-18% -$5M
EXAS
272
DELISTED
Exact Sciences
EXAS
$26.1M 0.08%
197,167
-49,744
-20% -$6.02M
SPG icon
273
Simon Property Group
SPG
$76.4B
$25.9M 0.08%
304,069
-91,696
-23% -$7M
TT icon
274
Trane Technologies
TT
$98.8B
$25.9M 0.08%
178,082
+6,944
+4% +$959K
EXC icon
275
Exelon
EXC
$48.1B
$25.5M 0.08%
846,488
+167,455
+25% +$4.94M

Similar funds

Axa's Q4 2020 Portfolio in Review

As of Q4 2020, Axa held 1,397 positions worth $31.9B, up 15% from $27.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2020 filing shows 111 new, 494 increased, 445 reduced and 146 closed positions. Its largest new stake was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M. The largest sale was Linde, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q4 2020 buy was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M.
  • Axa added most to Amazon in Q4 2020, an estimated $83.9M increase.
  • Axa's biggest Q4 2020 reduction was Linde, cutting an estimated $149M.
  • Axa fully exited Jumia Technologies in Q4 2020, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 19% of its $31.9B portfolio in Q4 2020.
  • Axa opened 111 new positions and closed 146 in Q4 2020.
  • Axa's portfolio value rose 15% quarter-over-quarter to $31.9B.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.